Key result
Metabolic syndrome in hypertensive patients significantly increased the prevalence of myocardial hypertrophy (75.4% vs 49.3%, p<0.001) but did not significantly affect left ventricular mass.
Why the study?
Does the presence of metabolic syndrome increase left ventricular mass and the prevalence of myocardial hypertrophy in patients with arterial hypertension?
Population
182 subjects, comprising 138 patients with arterial hypertension and 44 normotensive controls.
Comparison
Presence of metabolic syndrome (MetS) vs Absence of metabolic syndrome in hypertensive…
Design
Cross-sectional
Authors
Loading...
MetS may raise LVH prevalence without increasing mass in hypertensives; leaves open independent causal effects.
Observational (n=182)
Does the presence of metabolic syndrome increase left ventricular mass and the prevalence of myocardial hypertrophy in patients with arterial hypertension?
Absolute Event Rate: 75.4% vs 49.3%
p-value: p=<0.001
In patients with arterial hypertension, the presence of metabolic syndrome increases the prevalence of myocardial hypertrophy but does not significantly increase absolute left ventricular mass compared to hypertension alone.
Ivanović et al. (2008) conducted an observational in Arterial hypertension and metabolic syndrome (n=182). Metabolic syndrome vs. Hypertension without metabolic syndrome was evaluated on Prevalence of myocardial hypertrophy (p=<0.001). Metabolic syndrome in hypertensive patients significantly increased the prevalence of myocardial hypertrophy (75.4% vs 49.3%, p<0.001) but did not significantly affect left ventricular mass.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: